Tyrosine Kinase Inhibitors in Glioblastoma: Refining Precision Medicine

In this online program experts discuss recent advances in the use of tyrosine kinase inhibitors to optimize outcomes in patients with glioblastoma. Watch the on-demand Webcast and download the slides from a dynamic CCO symposium to learn more about how to optimize this approach in your clinical practice.

Share

Program Content

Activities

TKIs in GBM
Tyrosine Kinase Inhibitors in Glioblastoma: Refining Precision Medicine
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: January 17, 2020

Expires: January 15, 2021

Activities

NTRK in GBM
Targeting NTRK Gene Fusions in GBM
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 22, 2019

Expires: November 20, 2020

Multiple Receptor TKIs in GBM
Multiple Receptor TKIs in Recurrent GBM in the Absence of Actionable Targets
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 22, 2019

Expires: November 20, 2020

Clinical Trials in GBM
Current Clinical Trials and Unique Small Molecule Targets in GBM
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 22, 2019

Expires: November 20, 2020

Faculty

cover img faculity

Tom Mikkelsen, MD, FRCPC

Medical Director, Precision Medicine Program & Clinical Trials
Henry Ford Cancer Institute
Henry Ford Health System
Detroit, Michigan

cover img faculity

Manmeet S. Ahluwalia, MD, FACP

Professor, Department of Medicine
Clinic Lerner College of Medicine
Case Western Reserve Universtiy
Dean, Diane Miller Family Endowed Chair in Neuro-Oncology
Director, Brain Metastasis Research Program
Associate Director, Head of Operations
Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center
Neurological Institute of Cleveland Clinic
Cleveland, Ohio

cover img faculity

Rimas V. Lukas, MD

Associate Professor of Neurology (Neuro-oncology)
Feinberg School of Medicine
Northwestern University
Chicago, Illinois

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Bayer Healthcare Pharma